Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 91 for “"Interferon Beta"”.

  1. Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy

    … Multiple Sclerosis (RRMS), administration of interferon beta (IFNβ) - lb can lead to the development of anti- IFN β antibodies in some patients. These antibodies may attenuate the effects of IFNβ, resulting in resistance to therapy or to disease relapses. On the other hand, anti-IFNP …

    ubc Repository record for Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy (opens in a new tab) Download PDF for Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy (opens in a new tab)

  2. Neutralizing antibodies and the biological response to interferon-beta therapy

    Interferon-beta (IFN-beta) was the first disease modifying drug to be approved for the treatment of multiple sclerosis (MS). IFN-beta reduces relapse rates, relapse severity as well as slows the progression of disease burden. However, neutralizing antibodies (NAbs) occur in a proportion of patients …

    ubc Repository record for Neutralizing antibodies and the biological response to interferon-beta therapy (opens in a new tab) Download PDF for Neutralizing antibodies and the biological response to interferon-beta therapy (opens in a new tab)

  3. Pharmacogenomics of interferon-beta treatment in caucasian multiple sclerosis patients

    … (MS), disease modifying drugs (DMD), including interferon-beta (IFN-β), are administered to reduce the number of relapses and slow disease progression. While IFN-β is a safe and effective MS therapy, up to 50% of patients do not respond adequately to treatment. Determination of response status …

    adelaide Repository record for Pharmacogenomics of interferon-beta treatment in caucasian multiple sclerosis patients (opens in a new tab)

  4. Mechanism Of Interferon-Beta-Mediated Inhibition Of Il-8 Gene Expression

    … of a number of diseases, including cancer. Interferon-β (IFN-β), a Type I interferon, inhibits the expression of IL-8, but the details of this effect are not known. In this study we investigate transcriptional control of the IL- 8 gene and the mechanism by which IFN-β exerts inhibitory …

    uab Repository record for Mechanism Of Interferon-Beta-Mediated Inhibition Of Il-8 Gene Expression (opens in a new tab)

  5. Modulation systemischer Chemokinspiegel durch rekombinantes Interferon-beta bei Patienten mit multipler Sklerose

    … von Krankheitsschüben ist rekombinantes Interferon-β (IFN-β). Wirk- und Nebenwirkungsmechanismen des Medikaments werden bisher nur partiell verstanden. In der Pathogenese der MS spielt eine Familie chemotaktisch wirksamer Zytokine, der Chemokine, eine entscheidende Rolle. Ziel dieser …

    wurz-thes Repository record for Modulation systemischer Chemokinspiegel durch rekombinantes Interferon-beta bei Patienten mit multipler Sklerose (opens in a new tab)

  6. The role of glycogen synthase kinase 3-beta in interferon beta biology.

    … has been shown to induce the production of interferon-ß (IFN-ß) via the MyD88-independent pathway. Here we demonstrate that glycogen synthase kinase 3-ß (GSK3-ß) plays a fundamental role in this process. Suppression of GSK3-ß activity by pharmacological inhibition, siRNA-mediated gene …

    louisville Repository record for The role of glycogen synthase kinase 3-beta in interferon beta biology. (opens in a new tab)

  7. The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis

    … reason for a drug’s withdrawal from the market. Interferon-beta (IFN-β) is a commonly used disease-modifying drug for multiple sclerosis (MS) and is generally safe. However, 30-60% of IFN-β exposed patients experience liver aminotransferase elevations, with an unknown proportion experiencing more …

    ubc Repository record for The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis (opens in a new tab) Download PDF for The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis (opens in a new tab)

  8. Respiratory Syncytial Virus-infected Mesenchymal Stem Cells Regulate Immunity via Interferon-beta and Indoleamine-2,3-dioxygenase

    Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infection in young children worldwide, accounting for an estimated 33.8 million cases of respiratory disease, over 3 million of which require hospitalization, and between 66,000 and 199,000 deaths in this …

    usf Repository record for Respiratory Syncytial Virus-infected Mesenchymal Stem Cells Regulate Immunity via Interferon-beta and Indoleamine-2,3-dioxygenase (opens in a new tab)

  9. Charakterisierung der viralen Inhibition des Interferon beta-Induktionssystems und Identifikation interferon-modulierender Gene des Maus-Cytomegalovirus

    … Interaktionen zwischen MCMV und der IFNalpha /beta-Induktion zeigten, dass in infizierten Zellen nach der Erkennung viraler Komponenten die IFNalpha/beta-induzierenden Signalwege aktiviert werden, um die IFN-Produktion zu initiieren. Durch MCMV-kodierte Evasionsmechanismen wird die Expression …

    fu-berlin Repository record for Charakterisierung der viralen Inhibition des Interferon beta-Induktionssystems und Identifikation interferon-modulierender Gene des Maus-Cytomegalovirus (opens in a new tab)

  10. Untersuchung der Sicherheit und Verträglichkeit von Interferon-beta-1b bei Kindern und Jugendlichen mit Multipler Sklerose

    … in einer immunmodulatorischen Basistherapie mit Interferon-beta-1a (INFß-1a, i.m./ s.c.), Interferon-beta-1b (INFß-1b) oder Glatirameracetat. Für Beta-Interferone wurde hierbei die Sicherheit, Verträglichkeit und Effektivität, hier insbesondere die einer möglichst früh einsetzenden Behandlung, in …

    fu-berlin Repository record for Untersuchung der Sicherheit und Verträglichkeit von Interferon-beta-1b bei Kindern und Jugendlichen mit Multipler Sklerose (opens in a new tab)

  11. The Adaptation of Chinese Hamster Ovary Cells to Hypothermic Temperatures Increases Yields of Monomeric Recombinant Interferon-beta

    … level of cell specific expression of recombinant beta-interferon. The volumetric titre of beta-interferon was enhanced by 70% in stationary cultures and by more than 2-fold by application of a temperature-shift strategy involving a growth to production phase. However, the low temperature-adapted …

    manitoba Repository record for The Adaptation of Chinese Hamster Ovary Cells to Hypothermic Temperatures Increases Yields of Monomeric Recombinant Interferon-beta (opens in a new tab)

  12. Desenvolvimento de uma plataforma de produção de glicoproteínas por expressão heteróloga de sialiltransferase e interferon-beta em Leishmania tarentolae

    … proteínas recombinantes. Entre elas, a proteína interferon-β. Esta é uma molécula glicosilada utilizada no tratamento de doenças neurodegenerativas inflamatórias e autoimunes, como a esclerose múltipla e a artrite reumatoide. Embora o perfil de glicosilação de proteínas expressas em L. tarentolae …

    brazil-ufv Repository record for Desenvolvimento de uma plataforma de produção de glicoproteínas por expressão heteróloga de sialiltransferase e interferon-beta em Leishmania tarentolae (opens in a new tab)

  13. Characterization and Identification of Hepatocyte Stimulating Factor (HSF) as Interferon Beta 2 (IFNβ₂) and its Role in the Acute Phase Response of Liver

    … biochemical similarities to another cytokine, Interferonβ₂ (IFNβ₂), that had previously been cloned from fibroblasts and from T-lymphocytes. HSF and 1FNβ₂ showed immunological similarities on the basis of antibody binding and activity inhibition assays. Cloned IFNβ₂ from T-cells showed potent …

    mcmaster Repository record for Characterization and Identification of Hepatocyte Stimulating Factor (HSF) as Interferon Beta 2 (IFNβ₂) and its Role in the Acute Phase Response of Liver (opens in a new tab)

  14. Oral Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis: Systematic Review and Indirect Treatment Comparison

    … of oral therapies compared to placebo and interferon beta-1a in adults with relapsing-remitting multiple sclerosis (RRMS).</p> <p><strong><em> </em></strong></p> <p><strong><em>Search methods </em></strong></p> <p>We searched the MEDLINE, EMBASE, Cochrane Library, Web of Science (January …

    mcmaster Repository record for Oral Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis: Systematic Review and Indirect Treatment Comparison (opens in a new tab)

  15. Efeito do interferon beta, da ciclosporina A, do ebselen e da vitamina E no sistema colinérgico e purinérgico de ratos normais e submetidos à desmielinização pelo brometo de etídio

    … (HY) e ponte (PN) associado ao tratamento com interferon beta (IFN-b), ciclosporina A (CsA), vitamina E (vit E) e ebselen (Ebs). Além disso, também foi investigado o efeito in vitro do BE na atividade da AChE, juntamente com os parâmetros cinéticos dessa enzima no ST, HP, CC e CB de ratos …

    brazil-ufrgs Repository record for Efeito do interferon beta, da ciclosporina A, do ebselen e da vitamina E no sistema colinérgico e purinérgico de ratos normais e submetidos à desmielinização pelo brometo de etídio (opens in a new tab)

Page 1 of 5